Abacavir and Lamivudine (Teva Pharmaceuticals USA, Inc.)
Welcome to the PulseAid listing for the Abacavir and Lamivudine drug offered from Teva Pharmaceuticals USA, Inc.. This Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA],Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Teva Pharmaceuticals USA, Inc. |
| NON-PROPRIETARY NAME: | Abacavir and Lamivudine |
| SUBSTANCE NAME: | ABACAVIR SULFATE; LAMIVUDINE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA],Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, FILM COATED |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2016-09-29 |
| END MARKETING DATE: | 0000-00-00 |
Abacavir and Lamivudine HUMAN PRESCRIPTION DRUG Details:
| Item Description | Abacavir and Lamivudine from Teva Pharmaceuticals USA, Inc. |
| LABELER NAME: | Teva Pharmaceuticals USA, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 600; 300(mg/1; mg/1) |
| START MARKETING DATE: | 2016-09-29 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0093-5382_4ca540e7-006f-447b-8a19-263b63ecdb94 |
| PRODUCT NDC: | 0093-5382 |
| APPLICATION NUMBER: | ANDA079246 |
Other ABACAVIR SULFATE; LAMIVUDINE Pharmaceutical Manufacturers / Labelers:
